Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback